To evaluate the analgesic effect of patha nirgundi ghrita suppository in post operative pain in ano rectal surgeries

A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Patha (Cissampelos pareira) Nirgundi (Vitex negundo) Ghrita suppository and Paracetamol Suppository in Post Operative Pain in Ano Rectal Surgeries - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/078922

Enrollment

Registered

2025-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient experiencing pain post operatively in elective ano rectal surgeries

Exclusion criteria

Exclusion criteria: Patients having severe anemia ulcerative colitis crohns disease tuberculosis of the colon and rectum rectal prolapse and rectal cancer will be excluded in the trial

Design outcomes

Primary

Measure	Time frame
To study the Vednasthapan effect of patha nirgundi ghrita suppository in the post operative ano rectal surgeriesTimepoint: First dose of patha nirgundi ghrita suppository will be given on post operative day 0 and will be continue for 5 days and assessment will be done on post operative day 1 to day 5 and follow up after day 7.	—

Secondary

Measure	Time frame
To oberverd effect of Per rectal bleeding.Timepoint: First dose of patha nirgundi ghrita suppository will be given on post operative day 0 and will be continue for 5 days and assessment will be done on post operative day 1 to day 5 and follow up after day 7.	—

Countries

India

Contacts

Public ContactDr Amit A Paliwal

Dr D Y Patil College of Ayurved And Research Centre Pimpri Pune 18

dramitpaliwal@gmail.com8087975164

Outcome results